VALNEVA has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FU YU-SHOW, HARRISVACCINES INC and ONCOGENEX TECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Australia | 6 | |
#3 | United States | 6 | |
#4 | Brazil | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Organic fine chemistry | |
#6 | Chemical engineering | |
#7 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Mehtali Majid | 17 |
#2 | Guehenneux Fabienne | 12 |
#3 | Esnault Magali | 8 |
#4 | Moreau Karine | 8 |
#5 | Champion-Arnaud Patrick | 4 |
#6 | Leon Arnaud | 4 |
#7 | Majid Mehtali | 3 |
#8 | Pain Bertrand | 3 |
#9 | Valarche Isabelle | 3 |
#10 | Muraguchi Atsushi | 2 |
Publication | Filing date | Title |
---|---|---|
AU2011253998A1 | Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines | |
AU2007283564A1 | Method of production of transgenic avian using embryonic stem cells | |
AU2006234304A1 | Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |